US Patent 11338117 Implantable dual pathway therapeutic agent delivery port
Patent 11338117 was granted and assigned to TriSalus Life Sciences on May, 2022 by the United States Patent and Trademark Office.
All edits
Edits on 16 Oct, 2023
Golden AI
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Aravind Arepally0
David Benjamin Jaroch0
James E. Chomas0
Jennifer D. Lucky0
Patrick Charles McCain0
Edits on 7 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 3 Apr, 2023
Golden AI
Infobox
Patent Citations
Edits on 28 Mar, 2023
Golden AI
Infobox
Is a
Patent Applicant
Current Assignee
Patent Jurisdiction
Patent Number
113381170
Date of Patent
May 24, 2022
0Patent Application Number
164056050
Date Filed
May 7, 2019
0Patent Citations
Patent Primary Examiner
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 25 Sep, 2022
Golden AI
Infobox
Patent Citations
Edits on 22 Sep, 2022
Golden AI
Edits on 25 May, 2022
Golden AI
Edits made to:
Infobox (+19 properties)
Article (+423 characters)
US Patent 11338117 Implantable dual pathway therapeutic agent delivery port
Article
A treatment system includes a dual lumen catheter system. The first lumen is open to systemic circulation. The second lumen is open to a target delivery location. In an embodiment, a pressure-control element is provided that includes an expanded configuration adapted to constrain delivery through the second lumen to the target delivery location. Methods for treating tissues and organs via vascular pathways are provided.
Infobox
Is a
Patent applicant
Current assignee
Patent jurisdiction
Patent number
11338117
Date of patent
May 24, 2022
Patent application number
16405605
Date Filed
May 7, 2019
Patent citations
Patent primary examiner
Find more entities like US Patent 11338117 Implantable dual pathway therapeutic agent delivery port
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
